These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2106455)

  • 1. High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients.
    Karande VC; Jones GS; Veeck LL; Muasher SJ
    Fertil Steril; 1990 Mar; 53(3):486-9. PubMed ID: 2106455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone.
    Sills ES; Schattman GL; Veeck LL; Liu HC; Prasad M; Rosenwaks Z
    Fertil Steril; 1998 May; 69(5):831-5. PubMed ID: 9591488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment.
    Brzyski RG; Muasher SJ; Droesch K; Simonetti S; Jones GS; Rosenwaks Z
    Fertil Steril; 1988 Dec; 50(6):917-21. PubMed ID: 3144467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of elevated early follicular-phase follicle stimulating hormone (FSH) levels: observations in unstimulated in vitro fertilization cycles.
    Lindheim SR; Sauer MV; Francis MM; Macaso TM; Lobo RA; Paulson RJ
    J Assist Reprod Genet; 1996 Jan; 13(1):49-52. PubMed ID: 8825167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on folliculogenesis and in vitro fertilization outcome after the administration of follicle-stimulating hormone at different times during the menstrual cycle.
    Sharma V; Riddle A; Mason B; Whitehead M; Collins W
    Fertil Steril; 1989 Feb; 51(2):298-303. PubMed ID: 2492235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization.
    Hofmann GE; Toner JP; Muasher SJ; Jones GS
    J In Vitro Fert Embryo Transf; 1989 Oct; 6(5):285-9. PubMed ID: 2517294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Super high estradiol response to gonadotropin stimulation in patients undergoing in vitro fertilization.
    Diamond MP; Buchholz T; Boyers SP; Lavy G; Shapiro BS; DeCherney AH
    J In Vitro Fert Embryo Transf; 1989 Apr; 6(2):81-4. PubMed ID: 2498447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome.
    Scott RT; Toner JP; Muasher SJ; Oehninger S; Robinson S; Rosenwaks Z
    Fertil Steril; 1989 Apr; 51(4):651-4. PubMed ID: 2494082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression.
    Branigan EF; Estes MA
    Fertil Steril; 2000 Mar; 73(3):587-90. PubMed ID: 10689017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of a midcycle follicle-stimulating hormone boost in addition to human chorionic gonadotropin for timing of follicle aspiration in unstimulated in vitro fertilization cycles.
    Lindheim SR; Sauer MV; Francis MM; Macaso T; Lobo R; Paulson RJ
    Gynecol Obstet Invest; 1997; 43(2):76-8. PubMed ID: 9067710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing the stimulation dose of rFHS in unexpected poor responders is not associated with better IVF outcome.
    Tutuncu L; Dundar O
    Ginekol Pol; 2012 Feb; 83(2):111-5. PubMed ID: 22568355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GnRH antagonist in older IVF patients. Retrieval rates and clinical outcome.
    Chang PL; Zeitoun KM; Chan LK; Thornton MH; Sauer MV
    J Reprod Med; 2002 Apr; 47(4):253-8. PubMed ID: 12012875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.